Global BCL-2 (b-cell Lymphoma 2) Inhibitors Market 2024-2028

Description

List of Tables

The BCL-2 (B-Cell Lymphoma 2) inhibitors market is forecasted to grow by USD 2288.9 mn during 2023-2028, accelerating at a CAGR of 15.2% during the forecast period. The report on the BCL-2 (B-Cell Lymphoma 2) inhibitors market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising geriatric population globally, growing awareness about hematological malignancies, and high target affinity and specificity of BCL-2 inhibitors.

Technavio's BCL-2 (B-Cell Lymphoma 2) inhibitors market is segmented as below:

Market Scope
Base Year	2024
End Year	2028
Series Year	2024-2028
Growth Momentum	Accelerate
YOY 2024	12.86%
CAGR	15.2%
Incremental Value	$2288.9 mn

By Product

Combination therapy
Monotherapy

By Type

Diffuse large B-cell lymphoma (DLBCL)
Follicular lymphoma
Chronic lymphocytic leukemia
Mantle cell lymphoma (MCL)

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the increase in number of patient assistance programs as one of the prime reasons driving the BCL-2 (B-Cell Lymphoma 2) inhibitors market growth during the next few years. Also, growing approval of combination therapy and increase in development of novel formulations will lead to sizable demand in the market.

The report on the BCL-2 (B-Cell Lymphoma 2) inhibitors market covers the following areas:

BCL-2 (B-Cell Lymphoma 2) inhibitors market sizing
BCL-2 (B-Cell Lymphoma 2) inhibitors market forecast
BCL-2 (B-Cell Lymphoma 2) inhibitors market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading BCL-2 (B-Cell Lymphoma 2) inhibitors market vendors that include AbbVie Inc., Danaher Corp., Amgen Inc., Ascentage Pharma Group International, AstraZeneca PLC, BeiGene Ltd., Bio Techne Corp., Biorbyt Ltd., Bristol Myers Squibb Co., F. Hoffmann La Roche Ltd., Ipsen Pharma, Merck and Co. Inc., Novartis AG, Santa Cruz Biotechnology Inc., Seagen Inc., Les Laboratoires Servier, and Eli Lilly and Co.. Also, the BCL-2 (B-Cell Lymphoma 2) inhibitors market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Product Code: IRTNTR72723

1 Executive Summary

1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market By Geographical Landscape
- Executive Summary - Chart on Market Segmentation by Product
- Executive Summary - Chart on Market Segmentation by Type
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning

2 Market Landscape

2.1 Market ecosystem
- Parent Market
- Data Table on - Parent Market
2.2 Market characteristics
- Market characteristics analysis
2.3 Value chain analysis
- Value Chain Analysis

3 Market Sizing

3.1 Market definition
- Offerings of companies included in the market definition
3.2 Market segment analysis
- Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
- Chart on Global - Market size and forecast 2023-2028 ($ million)
- Data Table on Global - Market size and forecast 2023-2028 ($ million)
- Chart on Global Market: Year-over-year growth 2023-2028 (%)
- Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

4.1 Global BCL-2 (B-Cell Lymphoma 2) Inhibitors Market 2018 - 2022
- Historic Market Size - Data Table on Global BCL-2 (B-Cell Lymphoma 2) Inhibitors Market 2018 - 2022 ($ million)
4.2 Product segment analysis 2018 - 2022
- Historic Market Size - Product Segment 2018 - 2022 ($ million)
4.3 Type segment analysis 2018 - 2022
- Historic Market Size - Type Segment 2018 - 2022 ($ million)
4.4 Geography segment analysis 2018 - 2022
- Historic Market Size - Geography Segment 2018 - 2022 ($ million)
4.5 Country segment analysis 2018 - 2022
- Historic Market Size - Country Segment 2018 - 2022 ($ million)

5 Five Forces Analysis

5.1 Five forces summary
- Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
- Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Product

6.1 Market segments
- Chart on Product - Market share 2023-2028 (%)
- Data Table on Product - Market share 2023-2028 (%)
6.2 Comparison by Product
- Chart on Comparison by Product
- Data Table on Comparison by Product
6.3 Combination therapy - Market size and forecast 2023-2028
- Chart on Combination therapy - Market size and forecast 2023-2028 ($ million)
- Data Table on Combination therapy - Market size and forecast 2023-2028 ($ million)
- Chart on Combination therapy - Year-over-year growth 2023-2028 (%)
- Data Table on Combination therapy - Year-over-year growth 2023-2028 (%)
6.4 Monotherapy - Market size and forecast 2023-2028
- Chart on Monotherapy - Market size and forecast 2023-2028 ($ million)
- Data Table on Monotherapy - Market size and forecast 2023-2028 ($ million)
- Chart on Monotherapy - Year-over-year growth 2023-2028 (%)
- Data Table on Monotherapy - Year-over-year growth 2023-2028 (%)
6.5 Market opportunity by Product
- Market opportunity by Product ($ million)
- Data Table on Market opportunity by Product ($ million)

7 Market Segmentation by Type

7.1 Market segments
- Chart on Type - Market share 2023-2028 (%)
- Data Table on Type - Market share 2023-2028 (%)
7.2 Comparison by Type
- Chart on Comparison by Type
- Data Table on Comparison by Type
7.3 Diffuse large B-cell lymphoma (DLBCL) - Market size and forecast 2023-2028
- Chart on Diffuse large B-cell lymphoma (DLBCL) - Market size and forecast 2023-2028 ($ million)
- Data Table on Diffuse large B-cell lymphoma (DLBCL) - Market size and forecast 2023-2028 ($ million)
- Chart on Diffuse large B-cell lymphoma (DLBCL) - Year-over-year growth 2023-2028 (%)
- Data Table on Diffuse large B-cell lymphoma (DLBCL) - Year-over-year growth 2023-2028 (%)
7.4 Follicular lymphoma - Market size and forecast 2023-2028
- Chart on Follicular lymphoma - Market size and forecast 2023-2028 ($ million)
- Data Table on Follicular lymphoma - Market size and forecast 2023-2028 ($ million)
- Chart on Follicular lymphoma - Year-over-year growth 2023-2028 (%)
- Data Table on Follicular lymphoma - Year-over-year growth 2023-2028 (%)
7.5 Chronic lymphocytic leukemia - Market size and forecast 2023-2028
- Chart on Chronic lymphocytic leukemia - Market size and forecast 2023-2028 ($ million)
- Data Table on Chronic lymphocytic leukemia - Market size and forecast 2023-2028 ($ million)
- Chart on Chronic lymphocytic leukemia - Year-over-year growth 2023-2028 (%)
- Data Table on Chronic lymphocytic leukemia - Year-over-year growth 2023-2028 (%)
7.6 Mantle cell lymphoma (MCL) - Market size and forecast 2023-2028
- Chart on Mantle cell lymphoma (MCL) - Market size and forecast 2023-2028 ($ million)
- Data Table on Mantle cell lymphoma (MCL) - Market size and forecast 2023-2028 ($ million)
- Chart on Mantle cell lymphoma (MCL) - Year-over-year growth 2023-2028 (%)
- Data Table on Mantle cell lymphoma (MCL) - Year-over-year growth 2023-2028 (%)
7.7 Market opportunity by Type
- Market opportunity by Type ($ million)
- Data Table on Market opportunity by Type ($ million)

8 Customer Landscape

8.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

9.1 Geographic segmentation
- Chart on Market share By Geographical Landscape 2023-2028 (%)
- Data Table on Market share By Geographical Landscape 2023-2028 (%)
9.2 Geographic comparison
- Chart on Geographic comparison
- Data Table on Geographic comparison
9.3 North America - Market size and forecast 2023-2028
- Chart on North America - Market size and forecast 2023-2028 ($ million)
- Data Table on North America - Market size and forecast 2023-2028 ($ million)
- Chart on North America - Year-over-year growth 2023-2028 (%)
- Data Table on North America - Year-over-year growth 2023-2028 (%)
9.4 Europe - Market size and forecast 2023-2028
- Chart on Europe - Market size and forecast 2023-2028 ($ million)
- Data Table on Europe - Market size and forecast 2023-2028 ($ million)
- Chart on Europe - Year-over-year growth 2023-2028 (%)
- Data Table on Europe - Year-over-year growth 2023-2028 (%)
9.5 Asia - Market size and forecast 2023-2028
- Chart on Asia - Market size and forecast 2023-2028 ($ million)
- Data Table on Asia - Market size and forecast 2023-2028 ($ million)
- Chart on Asia - Year-over-year growth 2023-2028 (%)
- Data Table on Asia - Year-over-year growth 2023-2028 (%)
9.6 Rest of World (ROW) - Market size and forecast 2023-2028
- Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
- Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
- Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
- Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
9.7 US - Market size and forecast 2023-2028
- Chart on US - Market size and forecast 2023-2028 ($ million)
- Data Table on US - Market size and forecast 2023-2028 ($ million)
- Chart on US - Year-over-year growth 2023-2028 (%)
- Data Table on US - Year-over-year growth 2023-2028 (%)
9.8 Canada - Market size and forecast 2023-2028
- Chart on Canada - Market size and forecast 2023-2028 ($ million)
- Data Table on Canada - Market size and forecast 2023-2028 ($ million)
- Chart on Canada - Year-over-year growth 2023-2028 (%)
- Data Table on Canada - Year-over-year growth 2023-2028 (%)
9.9 Germany - Market size and forecast 2023-2028
- Chart on Germany - Market size and forecast 2023-2028 ($ million)
- Data Table on Germany - Market size and forecast 2023-2028 ($ million)
- Chart on Germany - Year-over-year growth 2023-2028 (%)
- Data Table on Germany - Year-over-year growth 2023-2028 (%)
9.10 UK - Market size and forecast 2023-2028
- Chart on UK - Market size and forecast 2023-2028 ($ million)
- Data Table on UK - Market size and forecast 2023-2028 ($ million)
- Chart on UK - Year-over-year growth 2023-2028 (%)
- Data Table on UK - Year-over-year growth 2023-2028 (%)
9.11 France - Market size and forecast 2023-2028
- Chart on France - Market size and forecast 2023-2028 ($ million)
- Data Table on France - Market size and forecast 2023-2028 ($ million)
- Chart on France - Year-over-year growth 2023-2028 (%)
- Data Table on France - Year-over-year growth 2023-2028 (%)
9.12 Market opportunity By Geographical Landscape
- Market opportunity By Geographical Landscape ($ million)
- Data Tables on Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Opportunity/Restraints

10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2023 and 2028
10.4 Market opportunities/restraints

11 Competitive Landscape

11.1 Overview
11.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
11.3 Landscape disruption
- Overview on factors of disruption
11.4 Industry risks
- Impact of key risks on business

12 Competitive Analysis

12.1 Companies profiled
- Companies covered
12.2 Market positioning of companies
- Matrix on companies position and classification
12.3 AbbVie Inc.
- AbbVie Inc. - Overview
- AbbVie Inc. - Product / Service
- AbbVie Inc. - Key news
- AbbVie Inc. - Key offerings
12.4 Danaher Corp.
- Danaher Corp. - Overview
- Danaher Corp. - Business segments
- Danaher Corp. - Key news
- Danaher Corp. - Key offerings
- Danaher Corp. - Segment focus
12.5 Amgen Inc.
- Amgen Inc. - Overview
- Amgen Inc. - Product / Service
- Amgen Inc. - Key news
- Amgen Inc. - Key offerings
12.6 Ascentage Pharma Group International
- Ascentage Pharma Group International - Overview
- Ascentage Pharma Group International - Product / Service
- Ascentage Pharma Group International - Key offerings
12.7 AstraZeneca Plc
- AstraZeneca Plc - Overview
- AstraZeneca Plc - Product / Service
- AstraZeneca Plc - Key news
- AstraZeneca Plc - Key offerings
12.8 BeiGene Ltd.
- BeiGene Ltd. - Overview
- BeiGene Ltd. - Business segments
- BeiGene Ltd. - Key offerings
- BeiGene Ltd. - Segment focus
12.9 Bio Techne Corp.
- Bio Techne Corp. - Overview
- Bio Techne Corp. - Business segments
- Bio Techne Corp. - Key news
- Bio Techne Corp. - Key offerings
- Bio Techne Corp. - Segment focus
12.10 Biorbyt Ltd.
- Biorbyt Ltd. - Overview
- Biorbyt Ltd. - Product / Service
- Biorbyt Ltd. - Key offerings
12.11 Bristol Myers Squibb Co.
- Bristol Myers Squibb Co. - Overview
- Bristol Myers Squibb Co. - Product / Service
- Bristol Myers Squibb Co. - Key news
- Bristol Myers Squibb Co. - Key offerings
12.12 F. Hoffmann La Roche Ltd.
- F. Hoffmann La Roche Ltd. - Overview
- F. Hoffmann La Roche Ltd. - Business segments
- F. Hoffmann La Roche Ltd. - Key news
- F. Hoffmann La Roche Ltd. - Key offerings
- F. Hoffmann La Roche Ltd. - Segment focus
12.13 Merck and Co. Inc.
- Merck and Co. Inc. - Overview
- Merck and Co. Inc. - Business segments
- Merck and Co. Inc. - Key news
- Merck and Co. Inc. - Key offerings
- Merck and Co. Inc. - Segment focus
12.14 Novartis AG
- Novartis AG - Overview
- Novartis AG - Business segments
- Novartis AG - Key news
- Novartis AG - Key offerings
- Novartis AG - Segment focus
12.15 Santa Cruz Biotechnology Inc.
- Santa Cruz Biotechnology Inc. - Overview
- Santa Cruz Biotechnology Inc. - Product / Service
- Santa Cruz Biotechnology Inc. - Key offerings
12.16 Seagen Inc.
- Seagen Inc. - Overview
- Seagen Inc. - Key offerings
12.17 Les Laboratoires Servier
- Les Laboratoires Servier - Overview
- Les Laboratoires Servier - Business segments
- Les Laboratoires Servier - Key offerings
- Les Laboratoires Servier - Segment focus

13 Appendix

13.1 Scope of the report
13.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
13.3 Currency conversion rates for US$
- Currency conversion rates for US$
13.4 Research methodology
- Research methodology
13.5 Data procurement
- Information sources
13.6 Data validation
- Data validation
13.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
13.8 Data synthesis
- Data synthesis
13.9 360 degree market analysis
- 360 degree market analysis
13.10 List of abbreviations
- List of abbreviations